Bisphenol Mixtures at Human-Relevant Doses Disrupt Gene Expression in Donor Breast Organoids

Researchers grew 3D organoids from reduction mammoplasty tissue and exposed them for three weeks to individual endocrine disruptors, metabolic agents, carcinogens and their combinations. RNA sequencing and DNA methylation profiling revealed that the bisphenol cocktail shifted expression patterns linked to ductal morphogenesis and extracellular matrix remodeling in most donor lines, patterns that overlapped with invasive lobular carcinoma transcriptomes in public datasets. The design captured real-world mixture exposure and human tissue complexity better than prior rodent or 2D cell models, yet remained limited to short-term molecular readouts without functional tumor formation assays. Organoid work addresses a key gap left by animal studies whose mammary glands differ in branching architecture and hormone sensitivity, but it cannot yet establish whether the observed epigenetic shifts persist after exposure ends or translate into elevated cancer incidence decades later. Prior large cohort analyses, such as the Sister Study, have reported modest associations between urinary bisphenol levels and breast cancer risk, yet lacked tissue-level mechanistic data; the current findings supply one plausible intermediate phenotype while underscoring that mixture effects dominate single-compound signals. Next steps require longitudinal cohort studies that pair repeated biomonitoring with serial breast imaging or biopsy to test whether early molecular signatures predict later disease. Regulatory bodies could incorporate mixture testing into endocrine-disruptor evaluations if replication confirms dose-response consistency across additional donor populations.